Credits: Canva
This digital era is all about catching up with trends, TikToks and reels, but at the cost of what? Many believe all of this happens at the cost of one's health and mental well-being. As a result, the grades of students, especially in high school, when they are exposed to social media the most, start to drop. However, a study based on the University of Birmingham's findings, peer-revied and published by the Lancet's journal for European health policy compared 1,277 students and the rules their 30 different secondary schools had for smartphone use at break and lunchtimes.` The study found something else, contrary to the popular belief.
The study found that banning phones in school is not linked to pupils getting higher grades or having a better mental wellbeing. The study found that a student's sleep, classroom behavior, exercise or how long they spend on their phones did not seem much different for schools with phone bans versus schools without it.
However, the study did find that spending longer time in social media or on smartphones in general may be linked to such measures. This was the first study in the world that looked at school phone rules along with the children's health and education.
In an interview to the BBC, Dr Victoria Goodyear, study's lead author said, that the findings are not against smartphone bans in school, but, a suggestion that bans in isolation are not enough to tackle the negative impacts.
The focus must be on reducing how much time the student spends on their phone, which cannot just be supervised in school.
The schools were chosen from a sample of 1,341 mainstream state schools in England. Among these the behavior of student form schools that banned the smartphones versus those who did not ban it were studied to find out that schools restricting smartphone use did not seem to see the intended improvements on health, wellbeing and focus of the student, as one would have wished to.
The study also used the internationally recognized Warwick-Edinburg Mental Well-Being Scale, a measure of mental well-being focusing entirely on positive aspects. It is a 14-item scale with 5 response categories. This method was used to determine the wellbeing of the children who participated in the research. It further looked at students' anxiety and depression levels.
It also asked from teachers about whether their students were on target, below target or above target in English and maths.
When asked students, they said that the smartphone ban forces you to hang out and chat with your friends and some of them think in lower school, it has helped them spend less time scrolling social media and making lots of friends.
Experts point out that the important part is to help students learn to use their phone in a safe and controlled space. This way, phone-related issues, especially distraction, its impact on your mental health, will be much less. The answer is not ban, but the use of the smartphone in a controlled environment, so students learn to value the "freedom" they have been given to use them at break and lunch.
Credit: iStock
Glucagon-like peptide-1 (GLP-1) receptor agonists, such as Ozempic and Mounjaro, are best known for treating type 2 diabetes and obesity. However, a new study published in The BMJ suggests that people with diabetes using these blockbuster drugs may have an increased risk of hair loss (alopecia).
While the absolute risk is low, researchers from the University of Pennsylvania and the University of Southern California identified alopecia as a possible side effect of GLP-1 receptor agonists, particularly semaglutide and tirzepatide.
“GLP-1 receptor agonist use was associated with a higher risk of clinically recorded alopecia, particularly non-scarring alopecia, in patients with type 2 diabetes, compared with SGLT-2 and DPP-4 inhibitors,” the researchers wrote.
Non-scarring alopecia is a type of hair loss in which the hair follicles remain intact, making hair regrowth possible.
The researchers said the findings could help inform shared decision-making when considering GLP-1 receptor agonist therapy and highlight the need for further research into dermatological outcomes.
Researchers analyzed health data from 12,004 patients using GLP-1 receptor agonists and compared them with 15,221 patients using SGLT-2 inhibitors between January 2019 and September 2024. They also compared another 11,964 GLP-1 receptor agonist users with 11,233 DPP-4 inhibitor users.
The study found that adults using GLP-1 receptor agonists had:
Further analyses showed the association was specific to non-scarring alopecia, with a 53% higher risk compared with SGLT-2 inhibitors and a 72% higher risk compared with DPP-4 inhibitors.
The researchers noted that rapid weight loss is a well-established trigger of hair shedding and may also lead to iron or zinc deficiencies, disrupting the hair growth cycle.
They added that hormonal changes may also play a role, although further studies are needed to understand the underlying mechanisms.
The researchers acknowledged that they could not assess the severity, extent, duration, or reversibility of alopecia after treatment was stopped because of limited clinical information. They also could not rule out the influence of other unmeasured factors.
However, they said the study was based on high-quality data from a large, representative cohort, and the findings remained consistent across additional analyses.
“Our findings extend previous anecdotal safety signals and provide more systematic evidence to inform clinical awareness of this potential adverse effect,” the researchers concluded.
If you're experiencing excessive hair shedding while taking semaglutide, you may consider:
Credit: iStock
Between climbing the career ladder, raising kids, and keeping everything else running smoothly, there's rarely a spare moment when women should stop and check in with their own bodies.
Yet these same demanding years are often when certain autoimmune and chronic conditions first start to surface. The early signs tend to be so mild and easy to explain away that most women simply put them down to stress, lack of sleep, or an overly full plate.
Some of the autoimmune conditions that commonly fly under the radar include:
· Lupus
· Rheumatoid arthritis
· Sjogren’s syndrome
· Systemic sclerosis
· Psoriatic arthritis
Family history matters more than most women realize. Autoimmune conditions often have a genetic component, and having a parent, sibling, or close relative with an autoimmune disorder meaningfully raises the likelihood of developing one yourself, even if the specific condition isn't identical. If this applies to a woman, the symptoms below deserve even closer attention and a lower threshold for seeking medical advice, rather than waiting to see if they resolve on their own.
So, when should women get it checked? If any of these symptoms stick around rather than passing after a good night's sleep, it's worth paying attention:
· Fatigue that doesn't go away no matter how much rest you get
· Joint pain or stiffness, especially in the morning
· Unexplained aches in your muscles
· Skin rashes or a new sensitivity to sunlight
· Sudden shifts in your weight or energy levels
It is advised not to dismiss them, particularly if they've been going on for a few weeks. Early detection changes everything. It is observed that the difference between a manageable condition and a complicated one often comes down to how soon it was caught.
Diagnose early, and treatment can be initiated before the disease has a chance to progress, allowing a patient to continue living life on her own terms, not one dictated by illness.
That said, the fundamentals of good health have never changed, and we continue to emphasize routine check-ups, a balanced diet, adequate sleep, regular physical activity, and sound stress management. But if there is one thing every woman should take seriously, it is to learn to listen to your own body.
You know it better than anyone else. If something feels different, do not dismiss it or wait it out; seek an opinion. Awareness combined with timely action is what ultimately allows a woman to lead a full, active life both professionally and personally, well into her later years.
(Dr. Chirag Rajkumar Kopp, Consultant - Rheumatology & Clinical Immunology, Ramaiah Memorial Hospital, Bengaluru)
Credit: iStock/Instagram
In June, X-Men actor and former professional wrestler Tyler Mane revealed that he had been diagnosed with a "super-rare" form of breast cancer. The disease is uncommon in men, accounting for only about 1% of all breast cancer cases.
Now, as he undergoes treatment, the actor is encouraging men to pay attention to their health, have open conversations about family medical history, and never ignore unusual symptoms.
As he lost weight, he noticed a lump in his breast. Initially, he did not think it was serious and had it removed. However, laboratory tests revealed it was invasive ductal carcinoma, the most common form of breast cancer.
Following the diagnosis, Mane underwent genetic testing, where he found that he carries the BRCA2 gene mutation. The mutation significantly increases the risk of developing several cancers, including breast, prostate, pancreatic and, in women, ovarian cancer.
The discovery also made him realize how little he had discussed health issues with the men in his family.
Although the cancer was caught early, doctors determined it was aggressive enough to require chemotherapy after surgery.
"I was lucky enough that my breast cancer was stage 1. Men usually don't notice the signs or don't quickly treat breast cancer. By the time it's diagnosed, it is often stage 3 or 4, metastasized throughout their bodies, and then it becomes a whole different thing," he wrote in an interview with Yahoo.
Mane explained that the tumor measured 28 millimeters and had a surgical margin of less than one millimeter, making additional treatment like chemotherapy and radiation necessary.
The actor added that genomic testing showed a high risk of recurrence without treatment.
Mane is currently undergoing four rounds of chemotherapy followed by localized radiation therapy.
"I'm being treated with four rounds of chemo, and then I have to have some localized radiation treatment to make sure the cancer is all wiped out."
While treatment has been challenging, he said it is essential. "And let me tell you: Chemotherapy is not fun. But it is a necessity."
He also describing its side effects such as 'metal taste' hair loss and fatigue.
"They give you some really good steroids for the day before, the day of and the day after chemotherapy. But then when that wears off, it all kind of hits you. You get the metal taste in your mouth. You feel sluggish and want to sleep all the time. My beard fell out. I look like a hairless cat with a couple of tufts on my face now".
The actor admitted he initially underestimated the impact chemotherapy would have on his body. He also realized he had pushed himself too hard physically in an effort to stay strong.
Now, he is focusing on maintaining his strength by increasing his protein intake while continuing moderate exercise.
"Physically, I'm trying to keep up my protein intake to help me stay strong throughout treatment."
Despite the challenges, Mane has continued a daily workout routine that includes push-ups, squats and rebounding exercises.
Through his public updates and the podcast Mane hopes to raise awareness that breast cancer is not exclusively a women's disease. By sharing his experience, he wants more men to recognize the symptoms early, discuss their family medical history, and seek medical attention without delay.
© 2024 Bennett, Coleman & Company Limited